AbCellera Biologics Inc is an antibody discovery and development engine that’s specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company’s experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
2012
586
LTM Revenue $32.8M
LTM EBITDA -$224M
$344M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
AbCellera has a last 12-month revenue of $32.8M and a last 12-month EBITDA of -$224M.
In the most recent fiscal year, AbCellera achieved revenue of $38.0M and an EBITDA of -$192M.
AbCellera expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See AbCellera valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $485M | $38.0M | $31.6M | $32.8M | XXX |
Gross Profit | $330M | $419M | $38.0M | XXX | XXX |
Gross Margin | 68% | 1102% | 120% | XXX | XXX |
EBITDA | $276M | -$192M | -$222M | -$224M | XXX |
EBITDA Margin | 57% | -505% | -703% | -681% | XXX |
Net Profit | $153M | $159M | -$146M | XXX | XXX |
Net Margin | 32% | 417% | -464% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 7, 2025, AbCellera's stock price is $3.
AbCellera has current market cap of $916M, and EV of $344M.
See AbCellera trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$344M | $916M | XXX | XXX | XXX | XXX | $-0.59 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 7, 2025, AbCellera has market cap of $916M and EV of $344M.
AbCellera's trades at 10.5x LTM EV/Revenue multiple, and -1.5x LTM EBITDA.
Analysts estimate AbCellera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for AbCellera and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $344M | XXX | XXX | XXX |
EV/Revenue | 10.9x | XXX | XXX | XXX |
EV/EBITDA | -1.5x | XXX | XXX | XXX |
P/E | -5.2x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | -1.8x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAbCellera's NTM/LTM revenue growth is 39%
AbCellera's revenue per employee for the last fiscal year averaged $0.1M, while opex per employee averaged $0.4M for the same period.
Over next 12 months, AbCellera's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate AbCellera's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for AbCellera and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | -17% | XXX | XXX | XXX | XXX |
EBITDA Margin | -703% | XXX | XXX | XXX | XXX |
EBITDA Growth | 16% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | -664% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.1M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.4M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 37% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 160% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 462% | XXX | XXX | XXX | XXX |
Opex to Revenue | 687% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Jubilant Pharmova | XXX | XXX | XXX | XXX | XXX | XXX |
Biocon | XXX | XXX | XXX | XXX | XXX | XXX |
Syngene International | XXX | XXX | XXX | XXX | XXX | XXX |
Dishman Carbogen Amics | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
AbCellera acquired XXX companies to date.
Last acquisition by AbCellera was XXXXXXXX, XXXXX XXXXX XXXXXX . AbCellera acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was AbCellera founded? | AbCellera was founded in 2012. |
Where is AbCellera headquartered? | AbCellera is headquartered in United States of America. |
How many employees does AbCellera have? | As of today, AbCellera has 586 employees. |
Who is the CEO of AbCellera? | AbCellera's CEO is Dr. Carl L.G. Hansen, PhD. |
Is AbCellera publicy listed? | Yes, AbCellera is a public company listed on NAS. |
What is the stock symbol of AbCellera? | AbCellera trades under ABCL ticker. |
When did AbCellera go public? | AbCellera went public in 2020. |
Who are competitors of AbCellera? | Similar companies to AbCellera include e.g. Jubilant Pharmova, Biocon, Syngene International, Dishman Carbogen Amics. |
What is the current market cap of AbCellera? | AbCellera's current market cap is $916M |
What is the current revenue of AbCellera? | AbCellera's last 12-month revenue is $32.8M. |
What is the current EBITDA of AbCellera? | AbCellera's last 12-month EBITDA is -$224M. |
What is the current EV/Revenue multiple of AbCellera? | Current revenue multiple of AbCellera is 10.5x. |
What is the current EV/EBITDA multiple of AbCellera? | Current EBITDA multiple of AbCellera is -1.5x. |
What is the current revenue growth of AbCellera? | AbCellera revenue growth between 2023 and 2024 was -17%. |
Is AbCellera profitable? | Yes, AbCellera is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.